Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
Mayo Clinic · Mayo Clinic in Florida · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
933
total citations
- FWCI
- 42.69
- Percentile
- 100%
- References
- 35
Citations per year
Authors
10Topics & keywords
Topics
Keywords
- Medicine
- Lenalidomide
- Dexamethasone
- Multiple myeloma
- Clinical endpoint
- Thalidomide
- Internal medicine
- Interim analysis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.